Skip to main content
. 2022 Jan 25;9:784024. doi: 10.3389/fped.2021.784024

Figure 4.

Figure 4

Potential study design for a randomised study comparing chimeric antigen receptor (CAR) T-cell therapy with allogeneic haematopoietic stem cell transplantation (HSCT) in children with a first relapse of B-cell precursor acute lymphoblastic leukaemia. MRD, minimal residual disease; R, randomisation.